Professor David Fairlie

Professor David Fairlie is a Professor in the Department of Chemistry at The University of Queensland. His research focuses on Biological Drug Design, Medicinal Organic Chemistry, and Medicinal Chemistry, with an emphasis on Drug Design and Discovery. He is affiliated with the Institute for Molecular Bioscience (IMB) and maintains a group website at http://fairlie.imb.uq.edu.au. His work contributes to the understanding and development of therapeutic agents through interdisciplinary approaches in chemical biology.

David P Fairlie is a Professor at the University of Queensland, specializing in Chemistry, Pharmacology, Biochemistry, and Immunology. His research focuses on the development of peptide-based drugs, protease inhibitors, and the structural and functional analysis of proteins involved in neurodegenerative diseases such as Alzheimer's and Parkinson's. He investigates the role of metal ions in amyloid toxicity and explores therapeutic strategies targeting immune responses, including T-cell activation and complement receptors. His work also addresses the design of cyclic peptides and their potential for oral absorption, contributing to the advancement of drug delivery and immunotherapy.